» Articles » PMID: 16449817

Elevated Tryptase Levels Are Associated with Greater Bone Density in a Cohort of Patients with Mastocytosis

Overview
Date 2006 Feb 2
PMID 16449817
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mastocytosis is associated with a pathological increase in tissue mast cells. Associated skeletal problems include a decrease in bone density and pathological fractures.

Methods: In order to explore the relationship between bone density and the severity of mastocytosis, 21 patients with mastocytosis who underwent dual-energy X-ray absorptiometry were entered into this study. Correlation coefficients were computed between Z-scores and demographic, clinical and laboratory data. Femoral neck Z-scores correlated with serum tryptase levels when all the patients were considered (p=0.029).

Results And Conclusion: Patients with less severe disease had significantly lower values at the L1-L4 spine (p=0.046) and femoral neck (p=0.029) Z-scores compared to patients with more severe disease. Most patients who had low Z-scores (between -1 and -2.5) were under 50 years of age, had less severe disease and had lower serum tryptase levels. A history of gastroesophageal reflux disease and a history of hypotensive episodes correlated with lower L1-L4 spine Z-scores (p<0.05). Thus, patients with less severe disease and lower serum tryptase levels should in particular have their bone density determined with treatment appropriate to the findings.

Citing Articles

Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis.

Riffel J, Lubke J, Naumann N, Kreil S, Metzgeroth G, Fabarius A Sci Rep. 2022; 12(1):14228.

PMID: 35987779 PMC: 9392758. DOI: 10.1038/s41598-022-18537-6.


The Genetic Architecture of High Bone Mass.

Gregson C, Duncan E Front Endocrinol (Lausanne). 2020; 11:595653.

PMID: 33193107 PMC: 7658409. DOI: 10.3389/fendo.2020.595653.


Hematological Diseases and Osteoporosis.

Gaudio A, Xourafa A, Rapisarda R, Zanoli L, Signorelli S, Castellino P Int J Mol Sci. 2020; 21(10).

PMID: 32429497 PMC: 7279036. DOI: 10.3390/ijms21103538.


Endocrine manifestations of systemic mastocytosis in bone.

Greene L, Asadipooya K, Freitas Corradi P, Akin C Rev Endocr Metab Disord. 2016; 17(3):419-431.

PMID: 27239674 DOI: 10.1007/s11154-016-9362-3.


Osteoporosis and osteopathy markers in patients with mastocytosis.

Kanitez N, Erer B, Dogan O, Buyukbabani N, Baykal C, Sindel D Turk J Haematol. 2015; 32(1):43-50.

PMID: 25805674 PMC: 4439906. DOI: 10.4274/tjh.2013.0170.